Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles?

Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole

(2021) Malene Risum et al.   Antibiotics-Basel

Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center

(2020) Andrew M Borman et al.   MEDICAL MYCOLOGY

Isavuconazole therapeutic drug monitoring during long-term treatment for chronic pulmonary aspergillosis

(2020) Chris Kosmidis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

EASL Clinical Practice Guidelines: Drug-induced liver injury

(2019) Raúl Andrade et al.   JOURNAL OF HEPATOLOGY

Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy

(2019) E Furfaro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Inter-laboratory analysis of Isavuconazole plasma concentration assays among European laboratories

(2019) Federico Pea et al.   THERAPEUTIC DRUG MONITORING

Population Pharmacokinetics of Intravenous Isavuconazole in Solid Organ Transplant Recipients

(2019) Xuemei Wu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials

(2018) David Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

(2018) A.J. Ullmann et al.   CLINICAL MICROBIOLOGY AND INFECTION

Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations

(2017) Katharine E. Stott et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Hepatic veno-occlusive disease during isavuconazole administration

(2017) Alessio Mesini et al.   JOURNAL OF CHEMOTHERAPY

Improving outcome of fungal diseases - Guiding experts and patients towards excellence

(2017) Oliver A. Cornely et al.   MYCOSES

DrugBank 5.0: a major update to the DrugBank database for 2018

(2017) David S Wishart et al.   NUCLEIC ACIDS RESEARCH

Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)

(2016) Laura L. Kovanda et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment

(2016) Amit Desai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

(2016) Thomas F. Patterson et al.   CLINICAL INFECTIOUS DISEASES

Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis

(2016) Matt Shirley et al.   DRUGS

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints

(2016) Laura L. Kovanda et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

Isavuconazole

(2015) Natasha N. Pettit et al.   ANNALS OF PHARMACOTHERAPY

Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model

(2015) Seyedmojtaba Seyedmousavi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent

(2015) Jeffrey M. Rybak et al.   PHARMACOTHERAPY

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)

(2014) C.A. Kauffman et al.   Transplant Infectious Disease

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients

(2013) M. T. Montagna et al.   INFECTION

Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R

(2012) Michael N. Neely et al.   THERAPEUTIC DRUG MONITORING

Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis

(2008) Yasmine Nivoix et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES